LivaNova PLC (NASDAQ:LIVN) Director Daniel Jeffrey Moore sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $60.76, for a total value of $60,760.00. Following the sale, the director now directly owns 58,296 shares of the company’s stock, valued at $3,542,064.96. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Daniel Jeffrey Moore also recently made the following trade(s):
- On Monday, July 17th, Daniel Jeffrey Moore sold 1,000 shares of LivaNova PLC stock. The stock was sold at an average price of $61.55, for a total value of $61,550.00.
- On Thursday, June 15th, Daniel Jeffrey Moore sold 1,000 shares of LivaNova PLC stock. The stock was sold at an average price of $60.80, for a total value of $60,800.00.
Shares of LivaNova PLC (LIVN) traded down 0.46% on Friday, hitting $60.86. The company had a trading volume of 213,309 shares. The firm has a market capitalization of $2.97 billion, a P/E ratio of 108.68 and a beta of 0.62. LivaNova PLC has a 12-month low of $40.83 and a 12-month high of $64.95. The firm has a 50 day moving average of $61.56 and a 200-day moving average of $55.58.
LivaNova PLC (NASDAQ:LIVN) last released its quarterly earnings data on Wednesday, August 9th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.19. The firm had revenue of $321.40 million for the quarter, compared to analyst estimates of $315.75 million. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The business’s quarterly revenue was up .1% compared to the same quarter last year. On average, equities analysts predict that LivaNova PLC will post $3.20 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This article was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://stocknewstimes.com/2017/08/20/insider-selling-livanova-plc-livn-director-sells-60760-00-in-stock.html.
LIVN has been the subject of a number of recent research reports. BidaskClub downgraded LivaNova PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Berenberg Bank reaffirmed a “buy” rating and set a $70.00 price target on shares of LivaNova PLC in a research note on Friday, August 11th. Finally, WBB Securities downgraded LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 price target for the company. in a research note on Tuesday, August 15th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. LivaNova PLC has an average rating of “Hold” and an average target price of $58.00.
A number of hedge funds have recently added to or reduced their stakes in LIVN. Franklin Resources Inc. raised its stake in LivaNova PLC by 7.5% in the second quarter. Franklin Resources Inc. now owns 5,089,070 shares of the company’s stock valued at $311,515,000 after buying an additional 354,956 shares in the last quarter. FMR LLC raised its stake in LivaNova PLC by 74.9% in the first quarter. FMR LLC now owns 4,817,815 shares of the company’s stock valued at $236,118,000 after buying an additional 2,063,196 shares in the last quarter. BlackRock Inc. raised its stake in LivaNova PLC by 79.3% in the second quarter. BlackRock Inc. now owns 4,648,780 shares of the company’s stock valued at $284,552,000 after buying an additional 2,055,891 shares in the last quarter. State Street Corp raised its stake in LivaNova PLC by 74.8% in the second quarter. State Street Corp now owns 1,835,428 shares of the company’s stock valued at $112,345,000 after buying an additional 785,268 shares in the last quarter. Finally, Koch Industries Inc. acquired a new stake in LivaNova PLC during the second quarter valued at about $1,384,000. Hedge funds and other institutional investors own 75.01% of the company’s stock.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.
